In a 77‑year‑old male with hypertension, Barrett’s esophagus, COPD, interstitial lung disease, scleroderma, abdominal aortic aneurysm, chronic aspirin use, sucralfate, and proton‑pump inhibitor therapy, and laboratory findings of low hemoglobin, low serum iron, low ferritin, high total iron‑binding capacity, low transferrin saturation, microcytosis, elevated red cell distribution width, leukocytosis, and thrombocytosis, what are the likely causes of his anemia?

Likely Causes of Anemia in This Patient

This patient has classic iron deficiency anemia (IDA) with microcytosis, low ferritin (17 ng/mL), low serum iron (9 μg/dL), low transferrin saturation (2%), and elevated TIBC (421 μg/dL), despite a normal colonoscopy—the most likely culprits are chronic aspirin use causing occult upper GI blood loss, sucralfate-mediated impairment of iron absorption, and PPI-induced malabsorption of dietary iron.

Primary Mechanism: Iron Deficiency Anemia

The laboratory pattern is unequivocal for IDA 1:

• Ferritin 17 ng/mL (severely depleted iron stores)
• Transferrin saturation 2% (critically low, normal >20%)
• MCV 73 fL (microcytic)
• RDW 17.9% (elevated, indicating anisocytosis typical of IDA)
• Hemoglobin 10.0 g/dL (anemia)

Contributing Factors in This Patient

1. Medication-Induced GI Blood Loss and Malabsorption

Aspirin 81 mg daily is a well-established cause of chronic occult GI bleeding, particularly from gastric erosions and duodenal ulcers. Even low-dose aspirin causes measurable blood loss 1.

Sucralfate directly impairs iron absorption through binding mechanisms in the GI tract 2. The FDA label explicitly warns that sucralfate reduces bioavailability of multiple drugs through GI binding, and this same mechanism applies to dietary iron. This patient takes sucralfate four times daily, maximizing this interference.

Pantoprazole (PPI) reduces gastric acid, which is essential for converting dietary ferric iron (Fe³⁺) to absorbable ferrous iron (Fe²⁺). Long-term PPI use is a recognized cause of iron malabsorption 1.

2. Upper GI Source Despite Normal Colonoscopy

With Barrett's esophagus and chronic GERD requiring both PPI and sucralfate, this patient likely has chronic esophagitis or gastritis causing occult bleeding. The normal colonoscopy does not exclude upper GI pathology 1. British Society of Gastroenterology guidelines emphasize that patients with confirmed IDA warrant upper GI investigation even when lower GI evaluation is negative 1.

3. Reactive Thrombocytosis

Platelets 669 × 10⁹/L represents reactive thrombocytosis secondary to iron deficiency. Research demonstrates a significant negative correlation between serum iron and platelet count (r=-0.404, P<0.01), with transferrin saturation also negatively correlating with platelet count 3, 4. The more severe the iron deficiency, the higher the platelet count—this is a direct physiologic response.

4. Chronic Disease Contributions

Scleroderma with lung involvement may contribute through chronic inflammation, though the ferritin of 17 ng/mL argues strongly against anemia of chronic disease (which typically shows ferritin >100 ng/mL) 1.

Abdominal aortic aneurysm is associated with altered iron metabolism and local iron retention in the aneurysm wall, potentially contributing to systemic iron depletion 5. Research shows AAA patients have decreased circulating iron, transferrin, and hemoglobin compared to controls, with iron levels negatively correlating with aortic diameter.

5. Leukocytosis (WBC 15.9)

This likely reflects:

• Reactive leukocytosis from recent azithromycin course (suggesting recent infection)
• Possible chronic inflammatory state from scleroderma
• Stress response

This is not indicative of primary hematologic malignancy given the clear IDA pattern.

Clinical Pitfalls to Avoid

Do not assume the normal colonoscopy excludes GI blood loss. Upper endoscopy is mandatory in this patient with aspirin use, Barrett's esophagus, and severe IDA 1.

Do not overlook medication-induced malabsorption. The combination of sucralfate (binding) and PPI (acid suppression) creates a "double hit" preventing iron absorption even with adequate dietary intake.

Do not misinterpret the thrombocytosis as a primary disorder. This is reactive to iron deficiency and will resolve with iron repletion 3, 4.

Immediate Next Steps

1. Upper endoscopy to evaluate for esophagitis, gastritis, peptic ulcer disease, or other bleeding sources
2. Consider temporarily holding aspirin if upper GI pathology is identified
3. Space sucralfate dosing at least 2 hours away from iron supplementation 2
4. Initiate iron replacement therapy—given the severe deficiency and medication barriers to absorption, intravenous iron may be superior to oral iron in this patient 1
5. Monitor CBC and iron parameters after 8-12 weeks of treatment; expect platelet count to normalize with iron repletion